Journals / Türk Pediatri Arşivi / 2002 / Cilt: 30 - Sayı: 4

Cost-effectiveness in anaesthesia: Inhalation or total intravenous anaesthesia

Anestezide maliyet-etkinlik: İnhalasyon veya total intravenöz anestezi

Pages
166–170
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

As a conclusion; more cheaper anaesthetic methods can be formed via different anaesthetic drugs and combination of them.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Nowadays because of the wide spectrum of drugs and the commercial presentation forms of them which are whether used for inhalational anaesthesia (IA) or total intravenous anaesthesia (TIVA) are being interrogated for cost effectiveness.
📊
Key Findings & Data:After getting approval from the ethic committe 333 ASA-I-II class patients randomly received TIVA (n-209) or IA (n=124). 10 groups were classified due to contents of anaesthetic agent's commercial mg or mLform.
💡
Conclusion & Impact:As a conclusion; more cheaper anaesthetic methods can be formed via different anaesthetic drugs and combination of them.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Nowadays because of the wide spectrum of drugs and the commercial presentation forms of them which are whether used for inhalational anaesthesia (IA) or total intravenous anaesthesia (TIVA) are being interrogated for cost effectiveness. In this study indirect cost of frequently used anaesthetic methods are compared. After getting approval from the ethic committe 333 ASA-I-II class patients randomly received TIVA (n-209) or IA (n=124). 10 groups were classified due to contents of anaesthetic agent's commercial mg or mLform. Indirect cost related to anaesthetic methods were compared by using Mann-Whitney U test. It has been seen that indirect cost in TIVA groups which use midazolam was less than the TIVA groups which use propofol and also less than sevoflurane groups. Isoflurane group provided significant economic cost effectivenes compared to sevoflurane groups (p0.001). As a conclusion; more cheaper anaesthetic methods can be formed via different anaesthetic drugs and combination of them.

Özet

Günümüzde gerek inhalasyon anestezisi (İA) gerekse total İntravenöz anestezi (TİVA) yöntemlerinde kullanılan madde ve bu maddelerin ticari sunum formlarının geniş bir spektrum oluşturması, uygulamalara yönelik ekonomik maliyetlerin sorgulanmasına yol açmıştır. Bu çalışmada günümüzde sıklıkla uygulanan anestezi yöntemlerindeki indirekt maliyetlerin karşılaştırılması amaçlandı. Fakültemiz etik kurulundan onay alındıktan sonra 6 ay süreyle çalışmaya kabul edilen ASA-I-II grubu 333 hastaya rasgele TİVA (n=209) ve İA (n=124) yöntemi uygulandı. TİVA ve İA grupları idamede kullanılan anestezik ajanların ticari formlarında yer alan miktarlarının sırasıyla mg ve mL içeriklerine göre 10 grup oluşturuldu. Anestezi yöntemine bağlı indirekt maliyetler ikişerli gruplar halinde Mann-Whitney U testi kullanılarak karşılaştırıldı. Midazolamın uygulandığı TİVA gruplarında indirekt maliyetin propofolün kullanıldığı TİVA gruplarına ve sevofluran gruplarına göre daha ucuz olduğu görüldü (p

🔖

Cite This Article

ERHAN, Ö. L., BAYAR, M. K., YAŞAR, M. A., GÜN, A., AKIN, M. (2022). Cost-effectiveness in anaesthesia: Inhalation or total intravenous anaesthesia. Türk Pediatri Arşivi, Cilt: 30 - Sayı: 4, 166–170. https://ajindex.com/articles/641738

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (18)

  1. Kuvaki B: Anesteziyoloji uygulamasına giriş. Çeviri editörü: Elar Z,. In: Handbook of Clinical Aneshesia, Anestezi El Kitabı: İstanbul: Logos Yayıncılık 1999; s.24
  2. Kart A, Duman, Öztin C ve ark: Minimal akımlı anestezi idamesinde izofluran ve propofol maliyetinin karşılaştırılması. Anestezi Dergisi 2000; 8(2):84
  3. Thwaites A, Edmends S and Smith I: Inhalation induction with sevoflurane: a double-blind comparison with propofol. Br J Anaesth 1997; 78:356
  4. Kayhan Z: Klinik Anestezi. 2. baskı, İstanbul: Logos Yayıncılık 1997; p.83
  5. Doi M, İkeda K: Airway irritation produced by voletile anaesthetics during brief inhalation: comparison of halathone, enflurane, isoflurane and sevoflurane. Can J Anaesth 1993; 40:122
  6. Smith I, Ding Y, White PF: Comparison of induction, maintenance and recovery characteristics of sevoflurane-N2O and propofol-sevoflurane-N2O with propofol-isoflurane-N2O. Anesthesia and analgesia 1992; 74:253
  7. Mehernoor FW, Paul FW: Economics of anesthetic practice. Anaesthesiology 1997; 86:1170
  8. Witez T: Principles of cost analysis. J Clin Anaesth 1994; 6:357
  9. Dufek S, Gaucher E, Gianella J, et al: The total quality process applied to the operating rooms and other clinical process. Surgery 1993; 113:255
  10. Dennis MF, Aleks M: Economics of anesthesia care. Anesthesiology 1997; 86:1018
  11. Macario A, Vitez TS, Dunn B, McDonald T: Whre are the costs in perioperative care? Analysis of hospital cost are and changes for inpatient surgical care. Aneshesiology 1995; 83:1138
  12. Lubarsky DA, Sanderson IC, Gilbert WC, et al: The successful implementation of pharmaceutical practice guidelines. Anesthesiology 1997; 86:1145
  13. Lubarsky DA, Sanderson IC, Gilbert WC, et al: Using an anesthesia information management system as a cost containment tool. Aneshesiology 1997; 86:1167
  14. Detsky A, Naglie: A clinician’s guide to cost-effectiveness analysis. Ann İntern Med 1990; 133:147
  15. Robinson R: What does it mean? BMJ 1993; 307:670
  16. Alhashemi JA, Miller DR, O’Brien HV, Hull KA: Cost-effectiveness of inhalational, balanced and total intravenous anaesthesia for ambulatory surgery. Can J Anaesth 1997; 44(2):118
  17. Sung YF, Reiss N, Tillette T: The differential cost of anesthesia and recovery with propofol-Nitrous oxide anesthesia. J Clin Anesth 1991; 3:391
  18. Philip BK, Mushlin PS, Manzi D, Frieberger D, Roaf E: Isoflurane versus propofol for maintenance of anesthesia for ambulatory surgery. A comparison of cost and recovery p